MAbCross: antibody off-target prediction

MAbCross: antibody off-target prediction

Characterisation

Information

MAbCross; off-target identification from MAbSilico database (3,000 human proteins and 400,000 antibodies) Deliverable: list of up to 10 proteins per antibody in 10 days
MAbSilicoMAbSilico provides a formal embedded Artificial Intelligence technology for antibody discovery, reducing the risks of failure and the duration of discovery and preclinical steps, as well as strengthening intellectual property protection. Conventional approaches for the drug discovery take up to three years, while MAbSilico technologies allow shrinking this time to a few weeks. With lead selection, characterization and optimization, MAbSilico gives you AI-based solutions using antibody sequences and delivering qualified data within 10 days.

Log in

See all the content and easy-to-use features by logging in or registering!